학술논문
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance
Document Type
Article
Author
Source
In Biomedicine & Pharmacotherapy August 2023 164
Subject
Language
ISSN
0753-3322